Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Our head office and laboratories are located in Mississauga, Ontario, Canada. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon’s name; and, (ii) we develop and commercialize medical products for other medical companies under development and license contracts.  The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF.  Covalon is incorporated under the laws of Ontario.

Stock Info
Press Releases
Aug 24, 2020

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV); (OTCQX: CVALF), an advanced medical technologies company, today announces its third quarter fiscal 2020 results. Brian Pedlar,...

Aug 21, 2020

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2020 Third Quarter financial results on...

Jul 14, 2020

July 14, 2020 05:30 PM Eastern Daylight Time MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical...

View All

Email Alerts
* Required Fields
Monday, August 24, 2020
9:00am EDT
Wednesday, July 15, 2020
9:00am EDT

View All

Contact Us

For investor relations inquiries, please contact Brian Pedlar (CEO).
e-mail: bpedlar@covalon.com


To contact the Board of Directors to provide comments, report concerns or ask a question, please contact Abe Schwartz (Chair of the Board).
e-mail: abe@covalon.com

Contact Form